Watch Ticker

Checkpoint Therapeutics, Inc. Common Stock

Go to Checkpoint Therapeutics, Inc. Common Stock Website

$4.26

(%)

Live

Previous Close

$4.26

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

Day Vol.

Previous Day Vol.

Currency

Primary Exchange

Nasdaq

...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Globe Newswire - Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics

Fortress Biotech announced the closing of the sale of its subsidiary Checkpoint Therapeutics to Sun Pharmaceutical Industries Limited. The transaction will generate approximately $28 million for Fortress and a 2.5% royalty on net sales of Checkpoint's FDA-approved drug UNLOXCYT.

Related tickers: FBIO, FBIOP, CKPT.

Read Full Article

N/A - SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation into Fairness of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) Buyout Offer and Encourages Investors to Contact the Firm to Discuss Their Legal Rights and Options

Kaskela Law LLC is investigating the fairness of Checkpoint Therapeutics, Inc.'s proposed acquisition by Sun Pharmaceutical Industries Ltd. at $4.10 per share plus a contingent value right, as the buyout price is lower than analysts' price targets.

Related tickers: CKPT.

Read Full Article

Trending Tickers

Please sign in to view